Grann Pharmaceuticals

Pre-clinical

San Diego, United StatesFounded 2018grannpharma.com

Learn about Grann Pharmaceuticals' advancements in nucleic acid therapeutics, focusing on mRNA lipid nanoparticle technology for rare and genetic diseases.

Market Cap

Private

Pipeline

—

Patents

—

Publications

—

Private Company

Funding information not available

About

Learn about Grann Pharmaceuticals' advancements in nucleic acid therapeutics, focusing on mRNA lipid nanoparticle technology for rare and genetic diseases.

OncologySmall Molecules